nuclear medicine

SILICON VALLEY, Calif. & BEIJING, June 1, 2026 Haisco Pharmaceutical Group Co., Ltd. has announced a landmark licensing and...

PARIS, France, June 1, 2026 Curium, a global leader in radiopharmaceuticals and nuclear medicine, has announced a strategic investment...

BERLIN, Germany / WHIPPANY, N.J., May 7, 2026 Bayer announced positive topline results from the pivotal Phase III REVEAL...

ALBUQUERQUE, N.M., May 5, 2026 Eden Radioisotopes, LLC has filed a Construction Permit Application with the U.S. Nuclear Regulatory...

ATLANTA, Georgia, USA, April 28, 2026 PharmaLogic Holdings Corp., a leading contract development and manufacturing organization (CDMO) specializing in...

MELBOURNE, AUSTRALIA & INDIANAPOLIS, UNITED STATES — February 18, 2026 Telix Pharmaceuticals has submitted a European Marketing Authorization Application...

SYDNEY, Australia, Feb. 16, 2026 — Clarity Pharmaceuticals announced new clinical data from the Co-PSMA Investigator-Initiated Trial demonstrating that...

LONDON, UK, Feb. 12, 2026 — Serac Healthcare announced that the U.S. Food and Drug Administration has granted Fast...

Louvain-La-Neuve, Belgium, December 19, 2025 — IBA (Ion Beam Applications S.A.), a global leader in particle accelerator technology and...